SG Americas Securities’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Buy |
27,362
+17,111
| +167% | +$139K | ﹤0.01% | 1970 |
|
|
2025
Q1 | $80K | Sell |
10,251
-18,246
| -64% | -$142K | ﹤0.01% | 2751 |
|
|
2024
Q4 | $424K | Sell |
28,497
-1,572
| -5% | -$23.4K | ﹤0.01% | 1296 |
|
|
2024
Q3 | $460K | Sell |
30,069
-99,223
| -77% | -$1.52M | ﹤0.01% | 1554 |
|
|
2024
Q2 | $1.97M | Buy |
129,292
+120,650
| +1,396% | +$1.84M | 0.01% | 886 |
|
|
2024
Q1 | $163K | Sell |
8,642
-11,926
| -58% | -$225K | ﹤0.01% | 1895 |
|
|
2023
Q4 | $393K | Buy |
+20,568
| New | +$393K | ﹤0.01% | 1475 |
|
|
2023
Q2 | – | Sell |
-12,184
| Closed | -$222K | – | 2644 |
|
|
2023
Q1 | $222K | Sell |
12,184
-19,605
| -62% | -$357K | ﹤0.01% | 2134 |
|
|
2022
Q4 | $657K | Buy |
+31,789
| New | +$657K | 0.01% | 1159 |
|
|
2022
Q3 | – | Sell |
-37,557
| Closed | -$952K | – | 3061 |
|
|
2022
Q2 | $952K | Sell |
37,557
-56,629
| -60% | -$1.44M | 0.01% | 1201 |
|
|
2022
Q1 | $2.97M | Buy |
94,186
+68,297
| +264% | +$2.16M | 0.02% | 570 |
|
|
2021
Q4 | $1.05M | Sell |
25,889
-1,201
| -4% | -$48.6K | 0.01% | 1478 |
|
|
2021
Q3 | $945K | Buy |
+27,090
| New | +$945K | ﹤0.01% | 1802 |
|
|
2021
Q2 | – | Sell |
-7,201
| Closed | -$202K | – | 2791 |
|
|
2021
Q1 | $202K | Sell |
7,201
-4,668
| -39% | -$131K | ﹤0.01% | 2439 |
|
|
2020
Q4 | $308K | Sell |
11,869
-20,657
| -64% | -$536K | ﹤0.01% | 2060 |
|
|
2020
Q3 | $557K | Buy |
32,526
+17,863
| +122% | +$306K | ﹤0.01% | 1299 |
|
|
2020
Q2 | $363K | Buy |
14,663
+2,965
| +25% | +$73.4K | ﹤0.01% | 2032 |
|
|
2020
Q1 | $162K | Buy |
+11,698
| New | +$162K | ﹤0.01% | 2243 |
|
|
2019
Q2 | – | Sell |
-8,782
| Closed | -$110K | – | 2792 |
|
|
2019
Q1 | $110K | Buy |
+8,782
| New | +$110K | ﹤0.01% | 2625 |
|